Clinical Trial Update: Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

View source ↗

Summary

This clinical trial update describes a study using integrative multi-omics analysis to predict the clinical evolution of monoclonal gammopathies, including MGUS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma
• Smoldering Multiple Myeloma

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) | Status: RECRUITING